BROWN RUDNICK LLP for PRIME THERAPEUTICS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 1316-The Prescription Drug Price Transparency Act; S.637-Creating Transparency to Have Drug Rebates Unlocked Act of 2017; HR 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act; S.1003 relating to drug compendia & Medicaid drug payment. H.R. 1939 & S.1044-Ensuring Seniors Access to Local Pharmacies Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
| HENRY W MENN | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) |
Pharmacy PHA
S.469-The Affordable and Safe Prescription Drug Importation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
| HENRY W MENN | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) |
Health Issues HCR
H.R. 2015-The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; Issues relating to biosimilars and specialty pharmacy; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 1776 & S. 771-Improving Access to Affordable Prescription Drugs Act; H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 1628-The American Health Care Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
| HENRY W MENN | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.